The Epistemology of Cognitive Enhancement.

bioethics cognitive achievement cognitive enhancement epistemic value knowledge

Journal

The Journal of medicine and philosophy
ISSN: 1744-5019
Titre abrégé: J Med Philos
Pays: United States
ID NLM: 7610512

Informations de publication

Date de publication:
16 Mar 2019
Historique:
entrez: 17 3 2019
pubmed: 17 3 2019
medline: 16 7 2020
Statut: ppublish

Résumé

A common epistemological assumption in contemporary bioethics held by both proponents and critics of nontraditional forms of cognitive enhancement is that cognitive enhancement aims at the facilitation of the accumulation of human knowledge. This article does three central things. First, drawing from recent work in epistemology, a rival account of cognitive enhancement, framed in terms of the notion of cognitive achievement rather than knowledge, is proposed. Second, we outline and respond to an axiological objection to our proposal that draws from recent work by Leon Kass (2004), Michael Sandel (2009), and John Harris (2011) to the effect that "enhanced" cognitive achievements are (by effectively removing obstacles to success) not worthy of pursuit or are otherwise "trivial". Third, we show how the cognitive achievement account of cognitive enhancement proposed here fits snugly with recent active externalist approaches (e.g., extended cognition) in the philosophy of mind and cognitive science.

Identifiants

pubmed: 30877778
pii: 5381981
doi: 10.1093/jmp/jhy040
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

220-242

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press, on behalf of the Journal of Medicine and Philosophy Inc. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

J Adam Carter (JA)

University of Glasgow, Glasgow, UK.

Duncan Pritchard (D)

University of California, Irvine, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH